Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Athira Pharma, Inc. | VP of Finance | Common Stock | 76.6K | $43.4K | $0.57 | Oct 1, 2024 | Direct |
Athira Pharma, Inc. | VP of Finance | Restricted Stock Units | 37.1K | $21K | $0.57 | Oct 1, 2024 | Direct |
Athira Pharma, Inc. | VP of Finance | Stock Option (Right to Buy) | 37.1K | Oct 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ATHA | Athira Pharma, Inc. | Oct 1, 2024 | 2 | $0 | 4 | Oct 3, 2024 | VP of Finance |
ATHA | Athira Pharma, Inc. | Oct 1, 2024 | 0 | $0 | 3 | Oct 3, 2024 | VP of Finance |